Literature DB >> 19319666

Genetics of the P2X7 receptor and human disease.

Stephen J Fuller1, Leanne Stokes, Kristen K Skarratt, Ben J Gu, James S Wiley.   

Abstract

The P2RX7 gene is highly polymorphic, and many single nucleotide polymorphisms (SNPs) underlie the wide variation observed in P2X7 receptor responses. We review the discovery of those non-synonymous SNPs that affect receptor function and compare their frequencies in different ethnic populations. Analysis of pairwise linkage disequilibrium (LD) predicts a limited range of haplotypes. The strong LD between certain functional SNPs provides insight into published studies of the association between SNPs and human disease.

Entities:  

Year:  2009        PMID: 19319666      PMCID: PMC2686826          DOI: 10.1007/s11302-009-9136-4

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  28 in total

1.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

2.  P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder.

Authors:  Susanne Lucae; Daria Salyakina; Nicholas Barden; Mario Harvey; Bernard Gagné; Michel Labbé; Elisabeth B Binder; Manfred Uhr; Marcelo Paez-Pereda; Inge Sillaber; Marcus Ising; Tanja Brückl; Roselind Lieb; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Hum Mol Genet       Date:  2006-07-05       Impact factor: 6.150

3.  A 5' intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population.

Authors:  Kristen K Skarratt; Stephen J Fuller; Ronald Sluyter; Lan-Phuong Dao-Ung; Ben J Gu; James S Wiley
Journal:  FEBS Lett       Date:  2005-04-14       Impact factor: 4.124

4.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

5.  A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes.

Authors:  Giulio Cabrini; Simonetta Falzoni; Sylvia L Forchap; Patrizia Pellegatti; Alessandra Balboni; Paola Agostini; Antonio Cuneo; Gianluigi Castoldi; O Roberto Baricordi; Francesco Di Virgilio
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

6.  Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder.

Authors:  Nicholas Barden; Mario Harvey; Bernard Gagné; Eric Shink; Monique Tremblay; Catherine Raymond; Michel Labbé; André Villeneuve; Denis Rochette; Lise Bordeleau; Herbert Stadler; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

7.  A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages.

Authors:  Anne N Shemon; Ronald Sluyter; Suran L Fernando; Alison L Clarke; Lan-Phuong Dao-Ung; Kristen K Skarratt; Bernadette M Saunders; Khai See Tan; Ben J Gu; Stephen J Fuller; Warwick J Britton; Steven Petrou; James S Wiley
Journal:  J Biol Chem       Date:  2005-11-01       Impact factor: 5.157

8.  Human P2X7 pore function predicts allele linkage disequilibrium.

Authors:  Loren C Denlinger; Douglas B Coursin; Kathleen Schell; Giuditta Angelini; Dawn N Green; Arturo G Guadarrama; Jennifer Halsey; Usha Prabhu; Kirk J Hogan; Paul J Bertics
Journal:  Clin Chem       Date:  2006-04-13       Impact factor: 8.327

9.  The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations.

Authors:  J Burn; P Chapman; J Delhanty; C Wood; F Lalloo; M B Cachon-Gonzalez; K Tsioupra; W Church; M Rhodes; A Gunn
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

10.  An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor.

Authors:  Ben J Gu; Ronald Sluyter; Kristen K Skarratt; Anne N Shemon; Lan-Phuong Dao-Ung; Stephen J Fuller; Julian A Barden; Alison L Clarke; Steven Petrou; James S Wiley
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

View more
  52 in total

1.  Purinergic signaling: a fundamental mechanism in neutrophil activation.

Authors:  Yu Chen; Yongli Yao; Yuka Sumi; Andrew Li; Uyen Kim To; Abdallah Elkhal; Yoshiaki Inoue; Tobias Woehrle; Qin Zhang; Carl Hauser; Wolfgang G Junger
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

Review 2.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.

Authors:  Nishkantha Arulkumaran; Robert J Unwin; Frederick Wk Tam
Journal:  Expert Opin Investig Drugs       Date:  2011-04-21       Impact factor: 6.206

3.  Effect of P2X(7) receptor knockout on exocrine secretion of pancreas, salivary glands and lacrimal glands.

Authors:  Ivana Novak; Ida M Jans; Louise Wohlfahrt
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

4.  Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures.

Authors:  Niklas R Jørgensen; Lise B Husted; Kristen K Skarratt; Leanne Stokes; Charlotte L Tofteng; Torben Kvist; Jens-Erik B Jensen; Pia Eiken; Kim Brixen; Stephen Fuller; Rory Clifton-Bligh; Alison Gartland; Peter Schwarz; Bente L Langdahl; James S Wiley
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 5.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

6.  C terminus of the P2X7 receptor: treasure hunting.

Authors:  Helio Miranda Costa-Junior; Flávia Sarmento Vieira; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2011-01-27       Impact factor: 3.765

Review 7.  Neuronal P2X7 Receptors Revisited: Do They Really Exist?

Authors:  Peter Illes; Tahir Muhammad Khan; Patrizia Rubini
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

8.  The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases.

Authors:  Kiichi Nakahira; Shu Hisata; Augustine M K Choi
Journal:  Antioxid Redox Signal       Date:  2015-08-17       Impact factor: 8.401

9.  Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.

Authors:  Robert E Sorge; Tuan Trang; Ruslan Dorfman; Shad B Smith; Simon Beggs; Jennifer Ritchie; Jean-Sebastien Austin; Dmitri V Zaykin; Heather Vander Meulen; Michael Costigan; Teri A Herbert; Merav Yarkoni-Abitbul; David Tichauer; Jessica Livneh; Edith Gershon; Ming Zheng; Keith Tan; Sally L John; Gary D Slade; Joanne Jordan; Clifford J Woolf; Gary Peltz; William Maixner; Luda Diatchenko; Ze'ev Seltzer; Michael W Salter; Jeffrey S Mogil
Journal:  Nat Med       Date:  2012-03-25       Impact factor: 53.440

10.  Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis.

Authors:  S E Jamieson; A L Peixoto-Rangel; A C Hargrave; L-A de Roubaix; E J Mui; N R Boulter; E N Miller; S J Fuller; J S Wiley; L Castellucci; K Boyer; R G Peixe; M J Kirisits; L de Souza Elias; J J Coyne; R Correa-Oliveira; M Sautter; N C Smith; M P Lees; C N Swisher; P Heydemann; A G Noble; D Patel; D Bardo; D Burrowes; D McLone; N Roizen; S Withers; L M G Bahia-Oliveira; R McLeod; J M Blackwell
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.